Clinical Trials Directory

Trials / Completed

CompletedNCT00245427

Outcomes of Patients Not Responding to Antibiotics in the Community

Outcomes of Patients Not Responding to Outpatient Macrolide or b-Lactam Therapy for the Treatment of Community Acquired Pneumonia: Expansion to Include Acute Exacerbations of Chronic Bronchitis and Acute Sinusitis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
200 (actual)
Sponsor
CPL Associates · Academic / Other
Sex
All
Age
95 Years
Healthy volunteers
Not accepted

Summary

A study to report the outcomes of patients who fail to respond to beta-lactam and macrolide antibiotics in the community

Detailed description

To document and describe the clinical, microbiological, and pharmacoeconomic outcomes of two hundred patients who failed to respond to outpatient macrolide or beta-lactam therapy. Evaluable patients must have a positive culture obtained after they failed their initial macrolide or beta-lactam. The isolated pathogen must have a known MIC to the antibiotic class they failed to respond to (i.e. macrolide or b-lactam). The isolate must be available to be sent to the central laboratory for MIC testing

Conditions

Interventions

TypeNameDescription
DRUGall macrolide antibioticsVaries based on antibiotic
DRUGall beta-lactam antibioticsVaries based on antibiotic

Timeline

Start date
2005-12-01
Completion
2006-03-01
First posted
2005-10-28
Last updated
2007-10-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00245427. Inclusion in this directory is not an endorsement.